RA Capital Management, LLC, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 15,637 shares at $17.93 ($299K) on 2016-01-11, disclosed to the SEC on 2016-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.93 | 4,153 | $74K | 24.9% |
| 2 | $19.12 | 5,941 | $114K | 38.0% |
| 3 | $19.97 | 5,543 | $111K | 37.0% |
| Total | $19.10 avg | 15,637 | $299K | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |